Detalles de la búsqueda
1.
Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.
J Neurooncol
; 153(2): 211-222, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33768405
2.
Correction to: Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.
J Neurooncol
; 153(2): 223, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014425
3.
The GEM-handle as convenient labeling strategy for bimodal single-domain antibody-based tracers carrying 99mTc and a near-infrared fluorescent dye for intra-operative decision-making.
Front Immunol
; 14: 1285923, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38035094
4.
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs.
Front Pharmacol
; 14: 1266288, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781693
5.
Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain.
Cancers (Basel)
; 14(4)2022 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35205609
6.
In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors.
Contrast Media Mol Imaging
; 2021: 2853522, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987318
7.
Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small molecules.
EJNMMI Res
; 11(1): 47, 2021 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33970376
8.
In Vivo Evaluation of Indium-111-Labeled 800CW as a Necrosis-Avid Contrast Agent.
Mol Imaging Biol
; 22(5): 1333-1341, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514888
9.
Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
Cell Chem Biol
; 26(9): 1214-1228.e25, 2019 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31303578
Resultados
1 -
9
de 9
1
Próxima >
>>